What changed on EU cosmetic labels after 31 July 2026?

The EU fragrance-allergen deadline changed which newly placed cosmetics need expanded ingredient disclosure, while older stock has a separate sell-through period until 2028.

By Droplet EditorialPublished August 14, 2026Updated August 14, 2026Sources checked August 14, 2026

Direct answer

The EU did not require every cosmetic bottle on a shelf to receive a new label at midnight on 31 July 2026. The date was a placing-on-the-market deadline under Commission Regulation (EU) 2023/1545. Cosmetic products covered by the new fragrance-allergen rules that did not comply could be placed on the Union market only until that date. Products validly placed before the cutoff may continue to be made available until 31 July 2028.

For consumers, the practical result is a mixed-label period. A newly placed product may show a much longer list of individual fragrance allergens, while older compliant transition stock may retain the earlier label. A longer list does not automatically mean the fragrance formula became more allergenic or was reformulated. It may mean the disclosure rule changed.

What Regulation 2023/1545 expanded

The EU already required certain fragrance allergens to be named individually when they exceeded specified concentrations. Commission Regulation (EU) 2023/1545 expanded and reorganized those declarations after the Scientific Committee on Consumer Safety identified additional fragrance allergens associated with contact allergy.

The regulation retains the familiar declaration thresholds: more than 0.001% in leave-on products and more than 0.01% in rinse-off products for covered substances. These are disclosure thresholds, not universal thresholds below which allergy becomes impossible. A person already sensitized to a substance can react at an exposure that another person tolerates.

DateRegulatory meaningWhat a shopper may see
31 July 2026Last transition date for placing covered non-compliant products on the Union marketNewer production increasingly uses expanded allergen labels
1 August 2026 onwardNewly placed covered products must follow the expanded requirementsMore individual fragrance names may appear after parfum
Through 31 July 2028Transition stock placed by the earlier deadline may still be made availableOld and new label formats can coexist

“Placed on the market” is not the same as “sold to you”

EU product law distinguishes placing a product on the market from making it available. Placing generally concerns the first supply of an individual product on the Union market. Making available includes later supply through distribution and retail.

That distinction explains the two-year gap. Manufacturers and responsible persons received time to update products and packaging before the 2026 placement cutoff. Retail and distribution channels then received additional time to move stock that had already entered the market. A consumer can therefore buy an older-label product after July 2026 without that fact alone proving the retailer broke the rule.

The exact status of a product depends on its supply history and the regulation’s conditions. A consumer cannot determine the placing date from the ingredient list. Batch coding, responsible-person records, and distribution evidence matter to enforcement.

Why labels became longer

Fragrance is usually a complex mixture. Cosmetic labels can use parfum or aroma for the composition rather than list every fragrance material. The allergen rules create an exception: specified substances must also be named when their concentration exceeds the relevant threshold.

The expanded list means labels may now contain names that were previously contained within the parfum declaration. That can make the ingredient panel look like a new formula even when the scent is materially similar. It can also change the apparent order near the end because low-level ingredients can occupy the reorderable portion discussed in the 1% rule guide.

Consumers comparing an old bottle with a new webpage should therefore ask three separate questions:

  1. Did the formula change?
  2. Did only the required disclosure change?
  3. Are the products intended for the same market?

Without a brand notice, matching batch information, or responsible-person confirmation, the ingredient lists alone may not settle all three.

What the change can help with

Individual declaration is particularly useful for someone with a diagnosed fragrance allergy who knows the exact substance or related group to avoid. “Fragrance-free” and “unscented” are broad marketing signals. A named allergen gives a clinician and patient a more specific point of comparison.

The rule also improves machine readability. An ingredient scanner can recognize more declared substances instead of seeing only parfum. That does not make an automated verdict medically complete. A checker still cannot know undeclared concentrations, personal sensitization, impurities, exposure from other products, or whether a current package differs from an online list.

What it does not establish

Expanded disclosure is not a declaration that all fragrance is unsafe. It does not mean a substance below the threshold cannot matter to a highly sensitized individual. It does not establish that a product without a listed allergen is universally hypoallergenic.

The regulation’s purpose includes helping sensitized consumers avoid substances known to them. That is narrower and more useful than a generic clean-versus-toxic score. A product can be lawfully labeled and still be a poor fit for one person. Another person may tolerate the same formula without difficulty.

European Union and Northern Ireland

EU cosmetic rules apply across the Union and European Economic Area as incorporated. In the United Kingdom, the geography must be stated precisely. GOV.UK guidance for Northern Ireland explains that the EU Cosmetics Regulation applies in Northern Ireland under the Windsor Framework.

Products placed on the Northern Ireland market therefore follow that EU framework, including applicable amendments and the EU notification system. A product manufactured in Great Britain and moved into Northern Ireland is treated as an import for this purpose, with associated responsible-person and labeling obligations.

Great Britain is a separate answer

England, Scotland, and Wales use the Great Britain cosmetics regime. GOV.UK’s GB guidance describes a UK Responsible Person, the Submit Cosmetic Product Notifications service, and GB-specific legal updates.

A later EU amendment does not automatically become GB law merely because the pre-exit systems share a common origin. Brands may voluntarily use harmonized packaging across markets or disclose the expanded allergens on a GB package. That commercial choice should not be described as proof that the EU deadline itself legally applied throughout Great Britain.

MarketRegulatory frame for this changePractical label note
EU/EEARegulation 2023/1545Expanded declaration and EU transition dates apply
Northern IrelandEU Cosmetics Regulation under Windsor FrameworkEU-oriented label may also support EEA supply
Great BritainSeparate GB cosmetics regimeEU-style disclosure may appear, but legal basis must be checked separately
United StatesFDA cosmetic labeling lawUS fragrance disclosure rules are not the same as the EU expansion

How to compare an old and new bottle

Photograph the complete old panel, including batch code, responsible-person address, net amount, warnings, and directions. Compare it with the physical new package rather than relying only on a retailer’s webpage. Retail pages can lag behind reformulations or display another market’s list.

Look for changes before and after parfum, but do not stop there. A new preservative, emulsifier, active, or base ingredient can indicate a real reformulation. A cluster of newly named fragrance substances with the rest of the list unchanged may reflect expanded disclosure. Contact the responsible person when a diagnosed allergy makes the distinction important.

Droplet’s ingredient checker can normalize the visible names, and the comparison tool can separate shared and unique entries. Neither tool can determine supply-chain placement dates or certify allergy safety.

Practical checklist

  • Check whether the package is for the EU, Northern Ireland, Great Britain, or another market.
  • Treat 31 July 2026 as a placement deadline, not a universal shelf relabeling date.
  • Expect transition stock to coexist with expanded labels through July 2028.
  • Do not assume a longer allergen list proves reformulation.
  • Use known allergy names from qualified testing rather than broad ingredient fear lists.
  • Confirm high-stakes questions with the current physical package and responsible person.

A worked old-label versus new-label example

Imagine an eau de parfum sold in both Belfast and London. An older box lists “Parfum, Limonene, Linalool.” A newer box adds several individually named fragrance allergens while the first part of the formula remains unchanged. For an EU or Northern Ireland package newly placed after 31 July 2026, expanded disclosure is a plausible explanation. It is not proof that the fragrance concentrate changed, and it does not date when a particular unit reached a retailer.

The London unit is governed by the Great Britain regime. The manufacturer may still use the expanded list voluntarily to simplify packaging. Seeing the same longer list in Great Britain therefore does not prove that the EU amendment directly governs that sale. Seeing the shorter list after July 2026 does not by itself prove noncompliance either: market, placement date, transition stock, package origin, and exact threshold conditions all matter.

This is why a physical batch comparison should preserve photographs and the batch code. A search result or cached retailer image may represent a different market or formula generation. Regulatory deadlines apply to economic actions such as placing or making products available, not to the date a consumer happens to notice a bottle.

What changed for allergy-aware shoppers

More individual names can help a person with a known fragrance allergy screen labels more specifically. It does not turn the ingredient list into an allergy test. Declaration thresholds differ for leave-on and rinse-off products, exposure differs by use, and an individual can react below a labeling threshold. Cross-reactions and substances outside a person's tested allergens further limit a simple yes-or-no interpretation.

Use the exact allergen names supplied by a dermatologist or allergy specialist, check the intended market's physical label, and contact the responsible person when uncertainty affects use. A reformulated product should be treated as new evidence even when the product name and front design remain familiar.

Why the two-year sell-through period exists

Cosmetics move through manufacturing, responsible persons, distributors, warehouses, retailers, and consumers. A placement deadline allows the supply chain to stop introducing non-aligned newly placed stock, while a later make-available deadline allows compliant transition handling of stock already placed. That staged structure avoids the waste and operational disruption of removing every package on one date.

For content creators, the accurate dated claim is therefore: 31 July 2026 changed which products could newly enter the relevant EU and Northern Ireland supply chain under the amendment; it did not make every older bottle disappear. The next important date is 31 July 2028, subject to the exact regulation and any later legal change.

Thresholds still apply

Expanded disclosure does not mean every trace fragrance substance must appear on every package. Regulation 2023/1545 uses concentration thresholds, including different thresholds for leave-on and rinse-off products, and specifies substances through the annex. A substance can therefore be present below the applicable declaration threshold. The label improves screening but is not a complete quantitative fragrance composition.

When exact avoidance is medically important, check both the individually declared names and broader entries such as parfum or aroma. The responsible person can address product-specific questions that list order and retailer images cannot settle.

Source notes

Sources and regulatory status were checked on August 14, 2026.

Before the product touches your skin, check the label.

Droplet Skincare is the official home of Droplet. Droplet scans labels, checks claims, weighs profile fit, and turns product evidence into routine memory without ads or sponsored ranking.

Frequently asked questions

Did every EU cosmetic label change on 31 July 2026?

No. The date controls when non-compliant products could still be placed on the Union market. Qualifying stock placed before the deadline can remain available during the transition period.

Can old-label cosmetics still be sold in the EU?

Products covered by the transition and placed on the market by the deadline may continue to be made available until 31 July 2028, subject to the regulation’s conditions.

Do the new labels mean a fragrance formula changed?

Not necessarily. A longer ingredient list may reflect newly required individual allergen disclosure rather than a reformulation. Compare batch, formula, and brand notices before assuming the contents changed.

Does the EU rule apply in the United Kingdom?

It applies in Northern Ireland through the EU cosmetics framework under the Windsor Framework. Great Britain has a separate cosmetics regime and does not automatically adopt every later EU amendment.

Does allergen labeling prove a product is allergy-safe?

No. Disclosure helps sensitized consumers identify named substances, but thresholds, individual allergy, undeclared impurities, and other ingredients still limit what a label can guarantee.

This article provides educational label, evidence, and regulatory context. It is not medical advice, legal advice, diagnosis, treatment, or a product recommendation. Rules, products, and evidence can change; verify current official sources and packaging.